ABBV

$222.47 -0.38% $-0.84
Jun 16, 2026 04:00 AM

ABBV, or AbbVie Inc., is a global biopharmaceutical company that focuses on developing and marketing advanced therapies for complex diseases.

Scroll or pinch to zoom · drag to pan the chart

Updating chart…

Price chart bar size:

Share on:

Asset Summary

Loading summary…

Asset Performance Metrics and Risk Characteristics:

Metrics below use daily returns for Jan 1, 2026 – Jun 17, 2026 (YTD).

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. Using indicators such as moving averages, pivot levels, momentum studies, and candlestick pattern scans can clarify trend strength and volatility. The tabs below summarize moving averages, pivots, technical indicators, candlestick patterns, and recent prices for this symbol.

Analysis

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Optimize Your ABBV Trading Now

Discover unparalleled trading insights with OHLCX Platform. Our automated system offers advanced analysis and technical indicators for ABBV, aimed at optimizing your trading decisions. Start optimizing your trades today and get ahead in the market now!

Take Action Now

Frequently Asked Questions

ABBV does not undergo traditional rebalancing like an ETF, but it regularly assesses its product pipeline and strategic initiatives to optimize performance.

Key metrics include revenue growth, earnings per share (EPS), net income, and return on equity (ROE), which indicate the company’s financial health.

ABBV is managed through various therapeutic areas, including immunology, oncology, neuroscience, and virology, with a strong emphasis on research and development.

ABBV’s performance can be compared to other biopharmaceutical companies, focusing on product pipeline success, market share, and revenue growth.

Historically, ABBV has demonstrated strong performance, particularly driven by its flagship products in immunology and oncology.

As of the latest update, ABBV has a dividend yield of approximately 4.4%, reflecting its commitment to returning value to shareholders.

ABBV offers a range of pharmaceuticals, including treatments for immunological conditions, oncology therapies, and neuroscience-related medications.

Similar companies include Pfizer, Merck, and Johnson & Johnson, which also focus on pharmaceuticals and biopharmaceuticals.

ABBV typically distributes dividends on a quarterly basis, providing a steady income stream for investors.

Investors can purchase shares of ABBV through a brokerage account, as it is publicly traded on the New York Stock Exchange (NYSE) under the ticker symbol "ABBV."

Supercharge Your ABBV Trading Now

Discover unparalleled trading insights with ohlcx.com. Our automated system offers advanced analysis and technical indicators for ABBV, aimed at optimizing your trading decisions. Elevate your trading approach instantly and get ahead in the market now!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.